Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay

Clinical Biochemistry
Robert ChristensonShow-Hong Duh

Abstract

High-Sensitivity (hs) cardiac troponin (cTn) assays are categorized by two criteria: (i) cTn values above the limit of detection (LoD) for >50% of male and female healthy cohorts of ≥300 individuals; (ii) imprecision ≤10% total %CV for sex-specific 99th-percentile clinical decision values (CDVs). No documented hs-Tn assay has yet been FDA-cleared. The PATHFAST cTnI-II assay's LoD was 2.3 ng/L using CLSI EP-17. The AACC Universal Sample Bank of 847 healthy men (50.6%) and women (49.4%) was used to determine 99th-percentile CDVs with Nonparametric, Harrell-Davis and Robust modeling. Health/Medication questionnaires and Amino-terminal proBNP, Hemoglobin A1c and estimated Glomerular Filtration Rate surrogates excluded underlying health conditions. The cTnI-II test's total CV was 6.1% at 29 ng/L and 7.1% at 22 ng/L; the LoD was 2.3 ng/L. Of the full 847-member healthy cohort, 113 (13.3%) were excluded by abnormal surrogate biomarkers. The final 734-member healthy population had the following (% > LoD): overall, 487 (66.3%); women, 186 (52.8%); and men, 301 (78.8%). 99th-percentile CDVs by Nonparametric modeling were: 28 ng/L (90% CI: 20-30), overall final 732-member healthy population; 20 ng/L (90% CI: 13-30), 352 women; and 30 ng/L...Continue Reading

Citations

Oct 18, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Federica BragaMauro Panteghini
Jan 28, 2020·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Jason P StopyraSimon A Mahler
May 12, 2019·Der Internist·M VafaieE Giannitsis
Dec 7, 2020·Clinical Chemistry·Fred S AppleUNKNOWN IFCC Committee on Clinical Application of Cardiac Bio-Markers
Feb 27, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Evangelos GiannitsisKurt Huber
Jun 5, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Vinajak GopiEvangelos Giannitsis
Mar 14, 2020·Journal of the American College of Cardiology·Jasper BoeddinghausUNKNOWN APACE Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.